Insights

Trump/HHS Proposal to Change Federal Drug Rebates

What are the implications of the Dept. of Health and Human Services’ new plan to overhaul prescription drug rebates for federal beneficiaries?

Read ClearView’s overview of the proposal and perspectives on the key issues.

CLEARVIEW HEALTHCARE PARTNERS® is a registered trademark of ClearView Healthcare Partners, LLC in the United States, the UK, Switzerland, the European Union, and various other countries. All Rights Reserved.